2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary
- 10 November 2018
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 73 (24), 3168-3209
- https://doi.org/10.1016/j.jacc.2018.11.002
Abstract
No abstract availableThis publication has 238 references indexed in Scilit:
- Effects of a Fixed-Dose Combination Strategy on Adherence and Risk Factors in Patients With or at High Risk of CVDJAMA, 2013
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialThe Lancet, 2011
- Low frequency of primary lipid screening among Medicare patients with rheumatoid arthritisArthritis & Rheumatism, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trialsThe Lancet, 2010
- Major Lipids, Apolipoproteins, and Risk of Vascular DiseaseJAMA, 2009
- Ethnic differences in the relationship of carotid atherosclerosis to coronary calcification: The Multi-Ethnic Study of AtherosclerosisAtherosclerosis, 2008
- Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and WomenJAMA, 2007
- Safety and Efficacy of Statins in AsiansThe American Journal of Cardiology, 2007
- Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environmentClinical Pharmacology & Therapeutics, 2005